Liposomal Encapsulation Augments Delayed Hypersensitivity Reactions to Tuberculin Proteins

References

1. Burleson G. R., Kulpa C. F., de Matteis F. 1982; Old tuberculin associated with liposomes: A new interferon inducer.. Journal of Interferon Research 2:187–194
   [Google Scholar]
2. Eppstein D. A. 1982; Altered pharmacologic properties of liposome-associated human interferon-alpha 2.. Journal of Interferon Research 2:117–125
   [Google Scholar]
3. Fidler Raz A., Fogler W. E., Kirsh R., Bugelski P., Poste G. 1980; Design of liposomes to improve delivery of macrophage-augmenting agents to alveolar macrophages.. Cancer Research 40:4460–4466
   [Google Scholar]
4. Gregoriadis G. 1976; The carrier potential of liposomes in biology and medicine. 2.. New England Journal of Medicine 295:704–710
   [Google Scholar]
5. Gregordiadis G., Allison A. C. 1974; Entrapment of proteins in liposomes prevents allergic reactions in pre-immunised mice.. Febs Letters 45:71–74
   [Google Scholar]
6. Gupta K. C., Landi S. 1978; Isolation of tuberculin peptides from tuberculin purified protein derivative (PPD).. Canadian Journal of Microbiology 24:1242–1249
   [Google Scholar]
7. Heath T. D., Edwards D. C., Ryman B. E. 1976; The adjuvant properties of liposomes.. Biochemical Society Transactions 4:129–133
   [Google Scholar]
8. Kuwabara S. 1975; Purification and properties of tuberculin-active protein from Mycobacterium tuberculosis. Journal of Biological Chemistry 250:2556–2562
   [Google Scholar]
9. Landi S., Held H. R. 1980; Preparation and characterization of a large batch of tuberculin purified protein derivative (PPD-CT68).. Annali Sclavo 22:899–907
   [Google Scholar]
10. Landi S., Held H. R., Tseng M. C. 1970; Relationship between the molecular weight of tuberculoprotein and its biological potency.. Progress in Immunobiological Standardisation 4:512–520
    [Google Scholar]
11. Pimm M. V., Baldwin R. W. 1984; Tumour models for screening immunomodulators: Suppression of tumour growth by delayed hypersensitivity reactions.. Behring Institute Mitteilungen. 74:214–218
    [Google Scholar]
12. Pimm M. V., Embleton M. J., Perkins A. C., Price M. R., Robins R. A., Robinson G. R., Baldwin R. W. 1982; In vivo localization of anti-osteogenic sarcoma xenografts.. International Journal of Cancer 30:75–85
    [Google Scholar]
13. Poste G., Bucana C., Raz A., Bugelski P., Kirsh R., Fidler I. J. 1982; Analysis of the fate of systemically administered liposomes and implications for their use in drug delivery.. Cancer Research 42:1412–1422
    [Google Scholar]
14. Rosenthal S. R. 1980; Tuberculin sensitivity and BCG vaccination. In Rosenthal S. R. (ed) BCG vaccines: tuberculosis-cancer PSG Publishing Company Inc; Littleton, MA: pp 176–197
    [Google Scholar]